Poland, April 1 -- Poland based Astrazeneca Kft. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical products - Delivery of medicinal products containing active substances Trastuzumabum deruxtecan, Acalabrutinibum, Palivizumabum, Durvalumabum, Olaparibum, Ravulizumabum. The value of the contract is worth 164498213 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....